Who owns Aligos Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ALGS from SEC Form 13F filings across 31 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 31 institutions disclosed 2.3M shares of Aligos Therapeutics, Inc. worth $13.2M — about 22% of shares outstanding; the largest disclosed holder is Deep Track Capital, LP. Source: SEC Form 13F filings, parsed by EvidInvest.
31
13F holders
$13.2M
value, 2026 filers
22%
of shares outstanding (2.3M sh)
5
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of ALGS's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Deep Track Capital, LP | 444,110 | $2.6M | 0.0% | 4.3% | 0.0% |
| 2 | Alyeska Investment Group, L.P. | 412,000 | $2.4M | 0.0% | 3.9% | 0.0% |
| 3 | Sio Capital Management, LLC | 327,237 | $1.9M | 0.3% | 3.1% | 0.0% |
| 4 | MARSHALL WACE, LLP | 246,579 | $1.4M | 0.0% | 2.4% | -7.7% |
| 5 | Woodline Partners LP | 177,362 | $1.0M | 0.0% | 1.7% | 0.0% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 175,543 | $1.0M | 0.0% | 1.7% | -1.5% |
| 7 | BAKER BROS. ADVISORS LP | 83,055 | $479,227 | 0.0% | 0.8% | 0.0% |
| 8 | HHLR ADVISORS, LTD. | 76,247 | $439,945 | 0.1% | 0.7% | 0.0% |
| 9 | D. E. Shaw & Co., Inc. | 66,463 | $383,491 | 0.0% | 0.6% | +505.4% |
| 10 | UBS Group AG | 59,986 | $346,119 | 0.0% | 0.6% | +61.9% |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | 47,173 | $272,319 | 0.0% | 0.5% | -5.6% |
| 12 | JANE STREET GROUP, LLCNEW | 32,402 | $186,959 | 0.0% | 0.3% | new |
| 13 | BlackRock, Inc. | 30,292 | $174,785 | 0.0% | 0.3% | +132.3% |
| 14 | VANGUARD FIDUCIARY TRUST CO | 28,612 | $165,091 | 0.0% | 0.3% | +0.6% |
| 15 | DIMENSIONAL FUND ADVISORS LPNEW | 21,044 | $121,424 | 0.0% | 0.2% | new |
| 16 | Verition Fund Management LLC | 18,887 | $108,978 | 0.0% | 0.2% | 0.0% |
| 17 | Trexquant Investment LPNEW | 12,339 | $71,196 | 0.0% | 0.1% | new |
| 18 | RENAISSANCE TECHNOLOGIES LLC | 10,800 | $62,316 | 0.0% | 0.1% | -89.2% |
| 19 | Rockefeller Capital Management L.P. | 10,000 | $57,700 | 0.0% | 0.1% | 0.0% |
| 20 | Federation des caisses Desjardins du Quebec | 4,650 | $26,831 | 0.0% | 0% | +389.5% |
| 21 | Golden State Wealth Management, LLC | 2,674 | $15,429 | 0.0% | 0% | 0.0% |
| 22 | ROYAL BANK OF CANADA | 2,125 | $12,000 | 0.0% | 0% | 0.0% |
| 23 | CITIGROUP INCNEW | 1,808 | $10,432 | 0.0% | 0% | new |
| 24 | Tower Research Capital LLC (TRC) | 359 | $2,071 | 0.0% | 0% | +452.3% |
| 25 | JPMORGAN CHASE & CO | 344 | $1,868 | 0.0% | 0% | -49.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.